Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,912 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serial clinical and angiographic follow-up after phosphorylcholine-coated stent implantation.
Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y. Habara S, et al. Among authors: okamoto y. Int Heart J. 2011;52(2):88-91. doi: 10.1536/ihj.52.88. Int Heart J. 2011. PMID: 21483166 Free article.
Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis.
Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, Yamamoto H, Katoh H, Oka N, Fuku Y, Hosogi S, Hirono A, Maruo T, Tanaka H, Shigemoto Y, Hasegawa D, Tasaka H, Kusunose M, Otsuru S, Okamoto Y, Saito N, Tsujimoto Y, Eguchi H, Miyake K, Yoshino M. Habara S, et al. Among authors: okamoto y. JACC Cardiovasc Interv. 2011 Feb;4(2):149-54. doi: 10.1016/j.jcin.2010.10.012. JACC Cardiovasc Interv. 2011. PMID: 21349452 Free article. Clinical Trial.
The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis.
Habara S, Mitsudo K, Goto T, Kadota K, Fujii S, Yamamoto H, Kato H, Takenaka S, Fuku Y, Hosogi S, Hirono A, Yamamoto K, Tanaka H, Hasegawa D, Nakamura Y, Tasaka H, Otsuru S, Okamoto Y, Yamada C, Miyamoto M, Inoue K. Habara S, et al. Among authors: okamoto y. Heart. 2008 Sep;94(9):1162-5. doi: 10.1136/hrt.2007.128595. Epub 2007 Nov 21. Heart. 2008. PMID: 18032460
An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial study.
Miyoshi A, Nishii N, Kubo M, Okamoto Y, Fujii S, Watanabe A, Okawa K, Kawamoto K, Morita H, Ito H. Miyoshi A, et al. Among authors: okamoto y. J Cardiol. 2017 Nov;70(5):425-431. doi: 10.1016/j.jjcc.2017.05.004. Epub 2017 Jun 30. J Cardiol. 2017. PMID: 28673507 Free article.
Decreased Intrathoracic Impedance Associated With OptiVol Alert Can Diagnose Increased B-Type Natriuretic Peptide - MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) Study -.
Nishii N, Kubo M, Okamoto Y, Fujii S, Watanabe A, Toyama Y, Yamada T, Doi M, Morita H, Ito H; MOMOTARO Investigators. Nishii N, et al. Among authors: okamoto y. Circ J. 2015;79(6):1315-22. doi: 10.1253/circj.CJ-15-0076. Epub 2015 Mar 17. Circ J. 2015. PMID: 25787230 Free article.
Lifestyle Modification or Medication to Improve Condition of Patients With Asymptomatic Heart Failure　- Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization II (MOMOTARO II) Study.
Miyoshi A, Nishii N, Okamoto Y, Fujita S, Kawamoto K, Okawa K, Hiramatsu S, Nakamura K, Morita H, Ito H. Miyoshi A, et al. Among authors: okamoto y. Circ J. 2020 Feb 25;84(3):456-462. doi: 10.1253/circj.CJ-19-0986. Epub 2020 Feb 8. Circ J. 2020. PMID: 32037380 Free article. Clinical Trial.
Handgrip strength in patients with type 2 diabetes correlates with diabetic polyneuropathy. A single-center, retrospective observational study in Japanese patients.
Iwamoto Y, Nakanishi S, Komi M, Kimura Y, Watanabe Y, Sasaki T, Nakao E, Kubo M, Sugisaki T, Dan K, Okamoto Y, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Kimura T, Shimoda M, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: okamoto y. Endocr J. 2025 Jan 7. doi: 10.1507/endocrj.EJ24-0397. Online ahead of print. Endocr J. 2025. PMID: 39779215 Free article.
3,912 results